Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03477526
Recruitment Status : Terminated (PhD Student stopped working on this project)
First Posted : March 26, 2018
Last Update Posted : November 13, 2020
Sponsor:
Collaborator:
Lungenfibrose e.V.
Information provided by (Responsible Party):
Klaus Kenn, Schön Klinik Berchtesgadener Land

Brief Summary:
As the result of our last study "Long Term effects of an Inpatient Pulmonary Program in Patients with Pulmonary Fibrosis" already demonstrated the positive effects of a Pulmonary Rehabiliation on the mental status. In this current study the aim will be to analyse the personality type regarding anxiety and depression

Condition or disease Intervention/treatment Phase
Idiopathic Pulmonary Fibrosis and COPD Procedure: Pulmonary rehabilitation program Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 1 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Status and Develepment Mental Quality of Life in Lung Fibrosis in Comparison of COPD Inpatients Before and After Pulmonary Rehabilitation
Actual Study Start Date : February 26, 2019
Actual Primary Completion Date : February 27, 2019
Actual Study Completion Date : February 27, 2019


Arm Intervention/treatment
Experimental: COPD patients (GOLD stage III-IV) Procedure: Pulmonary rehabilitation program
3 weeks, ...

Active Comparator: IPF patients Procedure: Pulmonary rehabilitation program
3 weeks, ...




Primary Outcome Measures :
  1. Anxiety score [ Time Frame: 3 weeks ]
    Hospital Anxiety and Depression scale


Secondary Outcome Measures :
  1. Anxiety score [ Time Frame: 3 months ]
    Hospital Anxiety and Depression scale



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD GOLD III-IV
  • IPF according Pulmonary Guidelines

Exclusion Criteria:

< 30% FVC comorbidities with a negativ influence on the prognosis neurological and orthopaedic deficits, which make the participation of the pulmonary rehabilitation impossible non-compliance no written informed consent of the patient


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03477526


Locations
Layout table for location information
Germany
Schön Klinik Berchtesgadener Land
Schönau a.Königssee, Germany, 83471
Sponsors and Collaborators
Schön Klinik Berchtesgadener Land
Lungenfibrose e.V.
Layout table for additonal information
Responsible Party: Klaus Kenn, Principal Investigator, Schön Klinik Berchtesgadener Land
ClinicalTrials.gov Identifier: NCT03477526    
Other Study ID Numbers: Fibrosis 2016
First Posted: March 26, 2018    Key Record Dates
Last Update Posted: November 13, 2020
Last Verified: November 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Klaus Kenn, Schön Klinik Berchtesgadener Land:
pulmonary fibrosis
COPD
pulmonary rehabilitation
mental status (anxiety and depression)
quality of life
physical activity
Additional relevant MeSH terms:
Layout table for MeSH terms
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Fibrosis
Pathologic Processes
Lung Diseases
Respiratory Tract Diseases